1. Home
  2. KN vs ELVN Comparison

KN vs ELVN Comparison

Compare KN & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Knowles Corporation

KN

Knowles Corporation

N/A

Current Price

$24.95

Market Cap

2.0B

ML Signal

N/A

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

N/A

Current Price

$29.11

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KN
ELVN
Founded
1946
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
KN
ELVN
Price
$24.95
$29.11
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$22.33
$41.00
AVG Volume (30 Days)
553.8K
598.7K
Earning Date
05-08-2026
06-05-2026
Dividend Yield
N/A
N/A
EPS Growth
118.94
3.17
EPS
0.50
N/A
Revenue
$593,200,000.00
N/A
Revenue This Year
$9.40
N/A
Revenue Next Year
$6.98
$40.06
P/E Ratio
$50.84
N/A
Revenue Growth
7.17
N/A
52 Week Low
$12.19
$13.30
52 Week High
$28.74
$30.93

Technical Indicators

Market Signals
Indicator
KN
ELVN
Relative Strength Index (RSI) 42.02 55.70
Support Level $23.81 $18.89
Resistance Level $25.33 $29.63
Average True Range (ATR) 0.89 1.52
MACD -0.38 -0.07
Stochastic Oscillator 23.93 64.36

Price Performance

Historical Comparison
KN
ELVN

About KN Knowles Corporation

Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: